BAM
CHTP

Brave Asset Management’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Brave Asset Management’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,000
Closed -$17K – 456
2014
Q1 		$17K Hold
3,000
– – 0.01% 318
2013
Q4 		$13K Buy
+3,000
New +$10.1K 0.01% 327

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Brave Asset Management's CHTP Position: Q2 2014 in Review

Brave Asset Management sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 3,000 shares — an estimated $17K sold.

Brave Asset Management first reported a position in CHTP in Q4 2013 and held it in 2 quarters. The position peaked at $17K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Brave Asset Management reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Brave Asset Management sold 3,000 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $17K.
  • Brave Asset Management first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q4 2013 and held it in 2 quarters.
  • Brave Asset Management's CHELSEA THERAPEUTICS INT'L LTD position peaked at $17K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Brave Asset Management's 13F filing for Q2 2014, filed 11 Aug 2014.